| Plasmablastic Lymphoma studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT04915248Phase 2 · recruiting Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01961063Phase 1 · active not recruiting Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | AIDS-Related Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332507Phase 1 · recruiting Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma · condition mapped CURATED_BROADER · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05389423Phase 1 · recruiting Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06781359recruiting Study on Plasmablastic Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649304Phase 1 · not yet recruiting AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647432Phase 2/Phase 3 · not yet recruiting HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04139304early Phase 1 · recruiting A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05663502recruiting Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02797470Phase 1/Phase 2 · active not recruiting Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676360Phase 2 · terminated Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544019Phase 1 · recruiting Study of SGR-1505 in Mature B-Cell Neoplasms · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337985Phase 1 · active not recruiting Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | AIDS-Related Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07113496Phase 1 · not yet recruiting RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193842Phase 1/Phase 2 · completed Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01092182Phase 2 · completed Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02481310Phase 1/Phase 2 · unknown Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 18 trials mapped (14 active) | — | — | Plasmablastic Lymphoma | 1 | Observed | clinicaltrials | graph → |